Bivirkninger, der ikke blev observeret i kliniske forsøg, men som blev set i dyr ved ekspopsitionsniveauer svarende til eller lavere end kliniske ekspositionsniveauer og med mulig relevans ved klinisk brug, var som følger: øcellevakuolisering i pancreas (rotte), tubulær degeneration i testis (mus, rotte og abe), lymfoid atrofi (mus, rotte og abe), blandet celleinflammation i colon/ coecum (abe) og pulmonal phospholipidose (rotte).
Adverse reactions not observed in clinical studies, but seen in animals at exposure levels similar to or even lower than clinical exposure levels and with possible relevance to clinical use, were as follows: pancreatic islet cell vacuolation (rat), testicular tubular degeneration (mouse, rat and monkey), lymphoid atrophy (mouse, rat and monkey), mixed cell inflammation of the colon/ caecum (monkey), and pulmonary phospholipidosis (rat).